Company intelligence / Profile preview
Medical Developments International
Melbourne (Springvale and Scoresby), Victoria, Australiamedicaldev.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
MDI is a global leader in acute pain and respiratory products with products registered in over 40 countries. Their key products include Penthrox® (the "Green Whistle") for pain management and respiratory devices for asthma and COPD management.
- Therapeutic areas
- PulmonologyNeurology
- Modalities
- Pharmaceutical productsMedical devices
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
CSIRO (Australia's national science agency)
Beyond the preview
Go deeper on Medical Developments International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medical Developments International.